StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ZBHBullishAnalyst Target Updateanalyst
Medium materiality6/10

Wells Fargo upgrades Zimmer Biomet to Overweight

Nov 17, 2026, 3:14 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish on the upgrade and target gap, with moderate confidence given this is a single analyst view.

AI summary

What happened, with direct paths to the underlying reporting

Wells Fargo upgraded ZBH to Overweight and set a $123 target versus the posted price of $101.41, indicating a positive change in analyst stance.

  • Wells Fargo rating: Overweight; price target: $123.
  • ZBH was up 0.97% since the signal.

Key facts

  1. 01

    Target: $123

  2. 02

    Posted price: $101.41

  3. 03

    Analyst firm: Wells Fargo

  4. 04

    Analyst: Larry Biegelsen

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.